Tagista - instructions for use, analogs, reviews and release forms (tablets 8 mg, 16 mg and 24 mg) drugs for the treatment of dizziness, tinnitus and Meniere's disease in adults, children and pregnancy

In this article, you can read the instructions for using the drug Tagist. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Taghist in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues Tagisty in the presence of existing structural analogues. Use to treat dizziness, tinnitus and Meniere's disease in adults, children, as well as during pregnancy and lactation.

Tagist - a drug that improves the microcirculation of the labyrinth, used in the pathology of the vestibular apparatus. Betagistin (the active substance of the drug Taghist) acts mainly on the histamine H1 and H3 receptors of the inner ear and vestibular nuclei of the central nervous system. By direct agonistic action on histamine H1 receptors in the inner ear vessels, and also indirectly through exposure to histamine H3 receptors, it improves the microcirculation and permeability of capillaries, normalizes the pressure of the endolymph in the labyrinth and cochlea. At the same time, betagistin increases blood flow in the basilar artery.

Has a pronounced central effect, being an inhibitor of histamine H3 receptors in the nuclei of the vestibular nerve. Normalizes the conductivity in the neurons of the vestibular nuclei at the level of the brainstem.

The clinical manifestation of these properties is a decrease in the frequency and intensity of dizziness, a decrease in noise in the ears, and improvement in hearing in the event of a decrease in it.

Composition

Betahistine dihydrochloride + excipients.

Pharmacokinetics

Absorbed quickly. Binding to plasma proteins is low.It is almost completely excreted by the kidneys in the form of a metabolite (2-pyridylacetic acid) for 24 hours.

Indications

• treatment and prevention of vestibular vertigo of various origin;
• syndromes including dizziness and headache, tinnitus, progressive hearing loss, nausea and vomiting;
• disease or Meniere's syndrome.

Forms of release

Tablets 8 mg, 16 mg and 24 mg.

Instructions for use and dosing regimen

The drug is administered orally, with meals.

Tablets 8 mg - 1-2 tablets 3 times a day.

Tablets 16 mg - 1 / 2-1 tablets 3 times a day.

Tablets 24 mg - 1 tablet 2 times a day.

Improvement is usually noted already at the beginning of therapy, a stable therapeutic effect occurs after two weeks of treatment and may increase over several months of treatment. Treatment is long. The duration of treatment is determined individually.

Side effect

• gastrointestinal disorders;
• reactions of hypersensitivity (rash, itching, urticaria);
• angioedema.

Contraindications

• age under 18 years (due to lack of data);
• pregnancy (due to lack of data);
• lactation period (due to lack of data);
• hypersensitivity to any of the components of the drug.

Application in pregnancy and lactation

Due to the lack of data, Tagist is contraindicated in pregnancy and lactation.

Use in children

Contraindicated in children and adolescents under the age of 18 (due to lack of data).

special instructions

With caution should be prescribed drug Tagist with peptic ulcer of stomach and duodenum (including in the anamnesis), pheochromocytoma, bronchial asthma. These patients should be observed regularly during the treatment period.

Impact on the ability to drive vehicles and manage mechanisms

Betagistin has no sedative effect and does not affect the ability to drive a car or engage in activities requiring rapidity of psychomotor reactions.

Drug Interactions

Cases of interaction or incompatibility with other drugs are unknown.

Analogues of Tagist's drug

Structural analogs for the active substance:

• Asnithon;
• Betaver;
• Betagistin;
• Betaserc;
• Betacentrine;
• Vasoserk;
• Vestibo;
• Vestap;
• Denoise;
• The micrometer.

Similar medicines:

Other medicines: